Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.0005 | 1 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.00043 | 1 |
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.00043 | 1 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.00037 | 1 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.00033 | 1 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.00031 | 1 |